Questions about a paper in Science magazine led its editor in chief, Donald Kennedy, to publish an “editorial expression of concern” today that states that the report of a study about developing ...

- Results support ongoing Phase 1/2 AUGMENT-101 trial of Syndax Pharmaceuticals' lead Menin-MLL inhibitor, SNDX-5613, for the treatment of adults with relapsed/refractory acute leukemias, including ...

The move comes as several US federal agencies such as the National Institutes of Health and the Food and Drug Administration are shifting away from conducting studies on non-human primates. They are ...

It's no secret people's notions about artificial intelligence are generally ridiculous. They regularly impute a presence to what is really just a machine, much as Google former engineer Blake Lemoine ...